Home > Boards > US Listed > Cannabis > Zynerba Pharmaceuticals (ZYNE)

Questions and answers from who to whom?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Glider549 Member Profile
 
Followed By 15
Posts 1,340
Boards Moderated 0
Alias Born 01/23/14
160x600 placeholder
Zynerba Pharma Receives FDA Guidance For Phase 3 Trial Of Zygel; Street Sees 75% Upside TipRanks - 5/6/2021 5:01:38 AM
Zynerba receives FDA guidance for Phase 3 trial design for Zygel in rare genetic disorder Seeking Alpha - 5/5/2021 4:46:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2021 4:34:27 PM
Zynerba Pharmaceuticals Announces Phase 3 RECONNECT Trial Design for Zygel™ in Fragile X Syndrome GlobeNewswire Inc. - 5/5/2021 4:05:00 PM
Zynerba Pharmaceuticals Presents Two Posters at the Society of Biological Psychiatry 2021 Virtual Meeting GlobeNewswire Inc. - 4/29/2021 2:00:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/21/2021 9:02:25 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/21/2021 9:01:11 AM
Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the Society of Biological Psychiatry 2021 Virtual Meeting GlobeNewswire Inc. - 4/15/2021 7:30:00 AM
Zynerba Pharmaceuticals to Present at the Needham Virtual Healthcare Conference GlobeNewswire Inc. - 4/6/2021 7:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 3/11/2021 11:13:49 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/10/2021 7:17:20 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/10/2021 7:02:02 AM
Zynerba Pharmaceuticals EPS in-line Seeking Alpha - 3/10/2021 7:01:11 AM
Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights GlobeNewswire Inc. - 3/10/2021 6:45:00 AM
Zynerba Pharmaceuticals to Participate in the 33rd Annual ROTH Conference GlobeNewswire Inc. - 3/4/2021 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/10/2021 12:21:48 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/8/2021 6:07:20 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/25/2021 4:23:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/25/2021 4:21:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/25/2021 4:20:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/25/2021 4:16:36 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/8/2021 1:05:46 PM
Zynerba Pharmaceuticals to Present at Two January Virtual Investor Conferences GlobeNewswire Inc. - 1/4/2021 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2020 7:02:09 AM
Zynerba Pharmaceuticals Provides Regulatory Update on Zygel™ in Fragile X Syndrome GlobeNewswire Inc. - 12/17/2020 6:30:00 AM
Glider549   Friday, 10/04/19 08:40:18 AM
Re: nunaka post# 1978
Post # of 2652 
Questions and answers from who to whom?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences